Business · 23/12/2020Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 27 New Drug Applications from Hospira, Inc. and Others
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 27 new drug applications from multiple applicants, including Hospira, Inc., following a written notification that the drug products were no longer being marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →